PresentationGood morning, and welcome to the Avacta Group Plc investor presentation. [Operator Instructions] Before we begin, we'd like to submit the following poll. I'd now like to hand you over to Christina Coughlin, CEO. Good morning.Christina CoughlinCEO & Executive Director Thanks, Paul. Good morning, and thank you, everyone, for joining us for the data release for faridoxorubicin in Phase Ib in patients with salivary gland cancers. I'm joined today by 2 team members, our Chief Medical Officer, David L ...